跳至主要内容
临床试验/NCT06936137
NCT06936137招募中3 期

: EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)

Ain Shams University1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2025年4月20日最近更新:
干预措施

试验速览

阶段
3 期
状态
招募中
入组人数
180
试验地点
1
主要终点
To determine the effectiveness of probiotics to decrease the weight gained as a result of antipsychotic medications.

研究概览

简要总结

the goal of the study is to improve the quality of life of patients on antipsychotic medications and increase the rate of compliance to treatment.

Primary objective:

1.To determine the effectiveness of probiotics to decrease the weight gained as a result of antipsychotic medications.

Secondary objective:

  1. To determine the effect of probiotic supplementation on the psychological state of patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adult schizophrenia patients (18-45 years) on second generation antipsychotics Stable patients with a total positive and negative syndrome scale (PANSS) score of ≤
  • With more than 10% weight gain after taking atypical antipsychotics for at least 3 months with treatment duration not more than two years.

排除标准

  • Taking probiotics, fiber supplements, antibiotics and laxatives in the last 6 weeks.
  • Comorbid gastrointestinal diseases, including active peptic ulcer, uncontrolled and recurrent diarrhea, gastrointestinal bleeding, and digestive system neoplastic diseases.

研究组 & 干预措施

Probiotic supplementation (Lacteol fort 10 billion) which contains culture medium and lactobacillus

Experimental

干预措施: lactobacillus LS (Drug)

结局指标

主要结局

To determine the effectiveness of probiotics to decrease the weight gained as a result of antipsychotic medications.

时间窗: 12 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验